Project Grant HT94252510410
Award Date
5/15/25
Completion Date
5/14/28
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
The U.S. Department of Defense awarded a $350,848 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan to fund a 2-year research project titled "A Novel Strategy to Prevent Central Auditory Disorders After Blast Exposure." The project aims to develop a nanoparticle-based delivery system to administer therapeutics that can prevent hearing loss and other auditory impairments resulting from blast exposures...
This federal Project Grant award, valued at $402,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research at Case Western Reserve University to investigate the repurposing of an FDA-approved drug to mitigate noise-induced hearing loss. The research project, which runs from May 1, 2025 to April 30, 2027, will leverage the university's expertise in biomedical sciences, engineering, and healthcare...
The University of Miami received a $1,534,759 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "RESTORATION OF INNER EAR CELLS IN THE HEARING LOSS-ASSOCIATED HUMAN INNER EAR SYSTEM". This 3-year award, with a period of performance from September 30, 2023 to September 29, 2026, will support the university's biomedical research efforts focused on developing new treatments and...
This $1.42M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Miami to prevent hidden hearing loss and synaptopathy following noise overexposure through targeted temperature management. The 3-year grant, awarded on July 15, 2023, will fund this study focused on improving medical solutions for the battlefield and transforming health care for Service Members and the public through...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $358,245 Project Grant to the Massachusetts Eye And Ear Infirmary on May 15, 2024 for the project "IN SILICO SCREEN AND IN VIVO EVALUATION OF FDA-APPROVED DRUGS TO TREAT NOISE-INDUCED HEARING LOSS". The grant supports a two-year effort to screen FDA-approved drugs and evaluate the most promising compounds for their ability to protect against noise-induced hearing loss in cell...
The federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $357,989.00 to the University of Cincinnati to conduct research on "MAGNETOPHOTOTHERMAL NANOPARTICLE DRUG DELIVERY FOR TREATING NOISE-INDUCED HEARING LOSS". The award, effective from September 1, 2025 to August 31, 2027, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public....
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $371,627 to the University of Texas Medical Branch at Galveston (UTMB) to support research on "TARGETING RETINOID ACID METABOLIC PATHWAY TO TREAT NOISE-INDUCED HEARING LOSS". The research aims to investigate the use of selective CYP26 inhibitors as a treatment for noise-induced hearing loss, with potential to transform care for Service Members and...
The U.S. Defense Health Agency awarded a $825,000 Project Grant to Delix Therapeutics, Inc. in Palo Alto, CA under the Military Medical Research and Development program (CFDA 12.420). The funding will support the "DEVELOPMENT OF SMALL-MOLECULE TREATMENT FOR HEARING LOSS" over a 3-year period from June 1, 2024 to May 31, 2027. The Military Medical Research and Development program provides grants to academic institutions, research centers, and medical universities to conduct biomedical...
This $385,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Wayne State University's research to develop therapeutic approaches targeting spiral ganglion-cochlear nucleus synaptopathy. The two-year award, running from September 1, 2023 to August 31, 2025, aims to transform health care for Service Members and the American public through innovative and impactful biomedical research. As a prominent public...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $824,505 Project Grant to the Sunnybrook Research Institute in Canada. The funding will support novel therapeutic and delivery strategies for primary auditory neuron regeneration research over a 3-year period from August 1, 2024 to July 31, 2027. The Sunnybrook Research Institute, a leading Canadian biomedical research center, will leverage its expertise in neuroscience,...